Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.
about
Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment optionsFrom Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.Investigational antimicrobial agents of 2013.A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.Disarming bacterial virulence through chemical inhibition of the DNA binding domain of an AraC-like transcriptional activator protein.The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control studyBiosynthesis, characterization, and antimicrobial applications of silver nanoparticlesPrevious Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.The role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.Pharmacodynamic target attainment for various ceftazidime dosing schemes in high-flux hemodialysisNew insight on antimicrobial therapy adjustment strategies for gram-negative bacterial infection: A cohort study.Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients.Combating multidrug-resistant Gram-negative bacterial infections.Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistanceCeftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.Novel linear polymers able to inhibit bacterial quorum sensing.Multidrug resistant Gram-negative bacilli in lower respiratory tract infectionsCeftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains.An empiric antibiotic protocol using risk stratification improves antibiotic selection and timing in critically ill children.Transcriptional Responses of Escherichia coli to a Small-Molecule Inhibitor of LolCDE, an Essential Component of the Lipoprotein Transport Pathway.Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria.Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality.
P2860
Q21146707-4D0A15B3-13E7-4722-A33F-57BF2A2CB97BQ28552767-E34B6C1C-CE22-4510-8796-7D85DD9780B9Q33623048-428D6855-CDA0-4339-9ECB-118C0539C8E9Q33798438-E996CC08-461A-4878-B20C-22196D41AA02Q34058137-797746D7-6714-4B1A-A2D3-65D2996FC477Q34327857-C8492163-1BC0-44FC-917A-C7D5655EB645Q34375204-E5926711-9F22-435D-B546-E4C90F64DB0CQ34611874-5776A26F-0971-4B4F-A7B0-55632193C753Q34982570-B3F6CED6-867A-454C-82E4-F0DC38105436Q35047983-1A910059-227D-481D-AF5F-58B78B4A771CQ35284344-83D30C12-BB8C-49F2-85FE-4C5294F68E84Q37023242-9D76AEAB-C46D-4340-B051-378B843D16E7Q37184911-8F14C056-34FD-4FA9-99D0-78BB99538EFDQ37335646-03BEA9BB-BA39-42DC-AF80-034946E267DFQ37737270-8BA285F7-5305-43B1-B27E-144AE7121E44Q38059857-59679C81-4135-4CE5-88FB-A813EA07EB65Q38161570-4E72BB58-AEB8-4BC5-887B-8C640776719AQ38512609-88929D3F-D8E7-487F-A31F-F3A6DA054E44Q38544744-1C76C899-706C-479B-80CE-4B3A0D1E5074Q38740305-7138B2FF-9EB2-4EEE-9845-C66426B9BDBEQ38915890-DB7676F6-6275-4838-80F0-E080B6E6D797Q39221256-31F76C5D-8003-46D0-BC64-6494B3D17B7FQ40343676-4CD59CBE-3BA9-4678-B8B0-93C31C0D15C7Q40410833-77A35AC5-2119-4BCD-9672-962758AC49A4Q41658548-571307E2-DDC4-4F29-9EBF-2CF8C9BCD3B2Q41845992-17D5827D-8C5E-4963-9AE3-30777466DA0EQ42232091-1BD69D19-1443-4D3C-BE50-7AC3C2EC1387Q42260135-B192A770-A713-465E-B2D7-41F635D4846BQ42573644-7A0C35A7-0D71-44C0-9D5E-4E70B7725362Q55378575-B1577A18-FA76-4631-91F4-F863531A49C5
P2860
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Appraising contemporary strate ...... am-Negative Resistance Summit.
@ast
Appraising contemporary strate ...... am-Negative Resistance Summit.
@en
Appraising contemporary strate ...... am-Negative Resistance Summit.
@nl
type
label
Appraising contemporary strate ...... am-Negative Resistance Summit.
@ast
Appraising contemporary strate ...... am-Negative Resistance Summit.
@en
Appraising contemporary strate ...... am-Negative Resistance Summit.
@nl
prefLabel
Appraising contemporary strate ...... am-Negative Resistance Summit.
@ast
Appraising contemporary strate ...... am-Negative Resistance Summit.
@en
Appraising contemporary strate ...... am-Negative Resistance Summit.
@nl
P2093
P2860
P356
P1476
Appraising contemporary strate ...... am-Negative Resistance Summit.
@en
P2093
Andrew F Shorr
Marcos I Restrepo
Scott T Micek
Yoav Golan
P2860
P304
S33-55; quiz S56-8
P356
10.1093/CID/CIR475
P407
P478
53 Suppl 2
P577
2011-09-01T00:00:00Z